Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker

European Journal of Cancer

Volumn 49, Issue 9, 2013, Pages 2214-2222

  Morgan, Richard ^a   Bryan, Richard T ^b   Javed, Saqib ^a   Launchbury, Francesca ^a   Zeegers, Maurice P ^b   Cheng, K K ^b   James, Nicholas D ^b   Wallace, D Michael A ^b   Hurst, Carolyn D ^c   Ward, Douglas G ^b   Knowles, Margaret A ^c   Pandha, Hardev ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Biomarker; Bladder cancer; Diagnostic; EN2

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ENGRAILED 2; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER STAGING; CONCENTRATION (PARAMETERS); DIAGNOSTIC ACCURACY; DNA SYNTHESIS; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; HOMEODOMAIN PROTEINS; HUMANS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84877702496     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.01.019     Document Type: Article

References (22)

1. A. Jemal, R. Siegel, J. Xu, and E. Warde Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. K.D. Sievert, B. Amend, and U. Nagele Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27 2009 295 300
3. A. Stenzl, J. Hennenlotter, and D. Schilling Can we still afford bladder cancer? Curr Opin Urol 18 2008 488 492
4. B.W. van Rhijn, M. Burger, and Y. Lotan Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 2009 430 442
5. N.L. Martin, M.K. Saba-El-Leil, S. Sadekova, S. Meloche, and G. Sauvageau EN2 is a candidate oncogene in human breast cancer Oncogene 24 2005 6890 6901
6. R. Morgan, A. Boxall, and A. Bhatt Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer Clin Cancer Res 17 2011 1090 1098
7. H. Pandha, K.D. Sorensen, and T.F. Orntoft Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer BJU Int 110 2012 287 292
8. R. Morgan, L. Plowright, K.J. Harrington, A. Michael, and H.S. Pandha Targeting HOX and PBX transcription factors in ovarian cancer BMC Cancer 10 2010 89
9. R.A. Irizarry, B. Hobbs, and F. Collin Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
10. M.P. Zeegers, R.T. Bryan, and C. Langford The West Midlands Bladder Cancer Prognosis Programme: rationale and design BJU Int 105 2009 784 788
11. R.T. Bryan, W. Wei, and N.J. Shimwell Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer Proteomics Clin Appl 5 2011 493 503
12. R. Morgan Engrailed: complexity and economy of a multi-functional transcription factor FEBS Lett 580 2006 2531 2533
13. M.S. Zaghloul, and I. Gouda Schistosomiasis and bladder cancer: similarities and differences from urothelial cancer Expert Rev Anticancer Ther 12 2012 753 763
14. L.I. Budman, W. Kassouf, and J.R. Steinberg Biomarkers for detection and surveillance of bladder cancer Can Urol Assoc J 2 2008 212 221
15. D. Tilki, M. Burger, and G. Dalbagni Urine markers for detection and surveillance of non-muscle-invasive bladder cancer Eur Urol 60 2011 484 492
16. A. Alvarez, and V.B. Lokeshwar Bladder cancer biomarkers: current developments and future implementation Curr Opin Urol 17 2007 341 346
17. S. Sharma, C.D. Zippe, L. Pandrangi, D. Nelson, and A. Agarwal Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat J Urol 162 1999 53 57
18. E.D. King, J. Matteson, S.C. Jacobs, and N. Kyprianou Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression J Urol 155 1996 316 320
19. I. Brunet, C. Weinl, and M. Piper The transcription factor Engrailed-2 guides retinal axons Nature 438 2005 94 98
20. A. Joliot, A. Trembleau, G. Raposo, S. Calvet, M. Volovitch, and A. Prochiantz Association of engrailed homeoproteins with vesicles presenting caveolae-like properties Development 124 1997 1865 1875
21. E.P. Diamandis How are we going to discover new cancer biomarkers? a proteomic approach for bladder cancer Clin Chem 50 2004 793 795
22. M. Horstmann, O. Patschan, J. Hennenlotter, E. Senger, G. Feil, and A. Stenzl Combinations of urine-based tumour markers in bladder cancer surveillance Scand J Urol Nephrol 43 2009 461 466